{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:41:01Z","timestamp":1786635661349,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Saudi J Gastroenterol"],"published-print":{"date-parts":[[2009]]},"DOI":"10.4103\/1319-3767.56091","type":"journal-article","created":{"date-parts":[[2009,9,29]],"date-time":"2009-09-29T07:31:39Z","timestamp":1254209499000},"page":"225","source":"Crossref","is-referenced-by-count":9,"title":["Comparison of azithromycin and metronidazole in a quadruple-therapy regimen for Helicobacter pylori eradication in dyspepsia"],"prefix":"10.4103","volume":"15","author":[{"given":"Babak","family":"Abbaszadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahram","family":"Agah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Shazad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1319-3767.56091-1","first-page":"47","volume-title":"The current role of Helicobacter pylori eradication in clinical practice","author":"Hunt","year":"1995","journal-title":"Scand J Gastroenterol Suppl"},{"key":"key-10.4103\/1319-3767.56091-2","first-page":"138","volume-title":"Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH I study","author":"Lind","year":"1996","journal-title":"Helicobacter"},{"key":"key-10.4103\/1319-3767.56091-3","first-page":"913","volume-title":"A United States multicentre trial of dual and proton pump inhibitor based triple therapies for Helicobacter pylori","author":"Laine","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"key-10.4103\/1319-3767.56091-4","doi-asserted-by":"crossref","unstructured":"Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group. Gut 1997;41:8-13.","DOI":"10.1136\/gut.41.1.8"},{"key":"key-10.4103\/1319-3767.56091-5","unstructured":"IARC. Schistosomes, liver flukes and Helicobacter pylori. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Geneva: WHO Publications; 1994. p. 61."},{"key":"key-10.4103\/1319-3767.56091-6","first-page":"79","volume-title":"Intestinal metaplasia, atrophic gastritis and stomach cancer: Trends over time","author":"Sipponen","year":"1994","journal-title":"Eur J Gastroenterol"},{"key":"key-10.4103\/1319-3767.56091-7","first-page":"427","volume-title":"Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran","author":"Massarrat","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key-10.4103\/1319-3767.56091-8","first-page":"37","volume-title":"Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the North-West of Iran","author":"Malekzadeh","year":"2004","journal-title":"J Clin Pathol"},{"key":"key-10.4103\/1319-3767.56091-9","first-page":"16","volume-title":"Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis","author":"Marshall","year":"1987","journal-title":"Digestion"},{"key":"key-10.4103\/1319-3767.56091-10","first-page":"167","volume-title":"Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report","author":"Malfertheiner","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"key-10.4103\/1319-3767.56091-11","doi-asserted-by":"crossref","unstructured":"NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 1994;272:65-9.","DOI":"10.1001\/jama.272.1.65"},{"key":"key-10.4103\/1319-3767.56091-12","first-page":"60","volume-title":"Susceptibility of various strains of Helicobacter pylori to selected agents","author":"Siavoshi","year":"2000","journal-title":"Arch Iranian Med"},{"key":"key-10.4103\/1319-3767.56091-13","first-page":"1263","volume-title":"Low-\u2005versus high-dose azithromycin triple therapy for Helicobacter pylori infection","author":"Chey","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"key-10.4103\/1319-3767.56091-14","first-page":"1374","volume-title":"H pylori antibiotic resistance: Prevalence, importance, and advances in testing","author":"M\u03b9graud","year":"2004","journal-title":"Gut"},{"key":"key-10.4103\/1319-3767.56091-15","first-page":"497","volume-title":"Helicobacter pylori treatment: A practical approach","author":"Vakil","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"key-10.4103\/1319-3767.56091-16","first-page":"229","volume-title":"Helicobacter pylori diagnosis and management","author":"Vilaichone","year":"2006","journal-title":"Gastroenterol Clin North Am"},{"key":"key-10.4103\/1319-3767.56091-17","first-page":"1189","volume-title":"Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: Results of a randomized prospective single-centre study","author":"de","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key-10.4103\/1319-3767.56091-18","unstructured":"Mikaeli J, Mir-Nasseri MM, Manafi-Anari A. Evaluation of OAMB quadruple therapy for Helicobacter pylori eradication in patients with peptic ulcer disease and gastroduodenitis [in Persian] 2004;44:84-9."},{"key":"key-10.4103\/1319-3767.56091-19","doi-asserted-by":"crossref","unstructured":"Kaviani MJ, Malekzadeh R, Vahedi H, Sotoudeh M, Kamalian N, Amini M, et al. Various durations of a standard regimen (amoxicillin, metronidazole, colloidal bismuth subcitrate for 2 weeks or with additional ranitidine for 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled trial. Eur J Gastroenterol Hepatol 2001;13:915-9.","DOI":"10.1097\/00042737-200108000-00007"},{"key":"key-10.4103\/1319-3767.56091-20","first-page":"75","volume-title":"Gastric mucosal distribution and clinical efficacy of azithromycin in patients with Helicobacter pylori related gastritis","author":"Blandizzi","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/1319-3767.56091-21","first-page":"9","volume-title":"Low efficacy of an ultra-short term, once-daily dose triple therapy with omeprazole, azithromycin, and secnidazole for Helicobacter pylori eradication in peptic ulcer","author":"Silva","year":"2002","journal-title":"Rev Hosp Clin Fac Med Sao Paulo"},{"key":"key-10.4103\/1319-3767.56091-22","doi-asserted-by":"crossref","unstructured":"Ivashkin VT, Lapina TL, Bondarenko OY, Sklanskaya OA, Grigoriev PY, Vasiliev YV, et al. Azithromycin in a triple therapy for H.pylori eradication in active duodenal ulcer. World J Gastroenterol 2002;8:879-\u200582.","DOI":"10.3748\/wjg.v8.i5.879"},{"key":"key-10.4103\/1319-3767.56091-23","first-page":"361","volume-title":"Determination of azithromycin in gastric biopsy samples","author":"Krichhoff","year":"1999","journal-title":"Int J Clin Pharmacol Ther"},{"key":"key-10.4103\/1319-3767.56091-24","first-page":"66","volume-title":"The European meeting on Helicobacter pylori: Therapeutic news from Lisbon","author":"Peitz","year":"1998","journal-title":"Gut"},{"key":"key-10.4103\/1319-3767.56091-25","first-page":"997","volume-title":"Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxicillin and either clarithromycin or azithromycin","author":"Cammarota","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"key":"key-10.4103\/1319-3767.56091-26","first-page":"264","volume-title":"Azithromycin for the cure of Helicobacter pylori infection","author":"Di","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"key-10.4103\/1319-3767.56091-27","doi-asserted-by":"crossref","unstructured":"Ivashkin VT, Lapina TL, Bondarenko OY, Sklanskaya OA, Grigoriev PY, Vasiliev YV, et al. Azithromycin in a triple therapy for H.pylori eradication in active duodenal ulcer. World J Gastroenterol 2002;8:879-\u200582.","DOI":"10.3748\/wjg.v8.i5.879"}],"container-title":["Saudi Journal of Gastroenterology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:48:38Z","timestamp":1786632518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1319-3767.56091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"alternative-id":["56091"],"URL":"https:\/\/doi.org\/10.4103\/1319-3767.56091","relation":{},"ISSN":["1319-3767"],"issn-type":[{"value":"1319-3767","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}